N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Jan 2021
Historique:
received: 29 10 2020
revised: 31 12 2020
accepted: 31 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 14 9 2021
Statut: epublish

Résumé

N-linked glycosylation is a crucial post-translational modification involved in protein folding, function, and clearance. N-linked glycosylation is also used therapeutically to enhance the half-lives of many proteins. Antithrombin, a serpin with four potential N-glycosylation sites, plays a pivotal role in hemostasis, wherein its deficiency significantly increases thrombotic risk. In this study, we used the introduction of N-glycosylation sites as a tool to explore what effect this glycosylation has on the protein folding, secretion, and function of this key anticoagulant. To accomplish this task, we introduced an additional N-glycosylation sequence in each strand. Interestingly, all regions that likely fold rapidly or were surrounded by lysines were not glycosylated even though an N-glycosylation sequon was present. The new sequon in the strands of the A- and B-sheets reduced secretion, and the B-sheet was more sensitive to these changes. However, the mutations in the strands of the C-sheet allowed correct folding and secretion, which resulted in functional variants. Therefore, our study revealed crucial regions for antithrombin secretion and could potentially apply to all serpins. These results could also help us understand the functional effects of natural variants causing type-I deficiencies.

Identifiants

pubmed: 33419227
pii: ijms22020516
doi: 10.3390/ijms22020516
pmc: PMC7825591
pii:
doi:

Substances chimiques

Antithrombin Proteins 0
Mutant Proteins 0
Antithrombin III 9000-94-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI17/00050
Organisme : Instituto de Salud Carlos III
ID : PI18/00598
Organisme : Fundación Séneca
ID : 19873/GERM/15

Références

Nature. 2008 Oct 30;455(7217):1255-8
pubmed: 18923394
J Thromb Haemost. 2004 Dec;2(12):2170-7
pubmed: 15613023
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17146-51
pubmed: 20855577
Eur J Biochem. 1977 Aug 15;78(1):195-203
pubmed: 410640
PLoS One. 2014 Dec 08;9(12):e114454
pubmed: 25485983
Hepatology. 2013 May;57(5):2049-60
pubmed: 23197448
Sci Rep. 2015 Sep 02;5:13666
pubmed: 26329378
J Biol Chem. 2014 Dec 5;289(49):34049-64
pubmed: 25331949
Biochem J. 2016 Aug 1;473(15):2273-93
pubmed: 27470592
Blood. 2009 May 21;113(21):5314-22
pubmed: 19139080
Blood. 2012 Jul 26;120(4):900-4
pubmed: 22498748
PLoS One. 2012;7(3):e32444
pubmed: 22412873
J Thromb Haemost. 2012 Sep;10(9):1859-66
pubmed: 22758787
FEBS J. 2017 Jul;284(13):2110-2126
pubmed: 28504839
Biophys J. 2018 May 8;114(9):2083-2094
pubmed: 29742402
Am J Hematol. 1994 Apr;45(4):321-4
pubmed: 8178802
Semin Cell Dev Biol. 2015 May;41:71-8
pubmed: 25460543
Thromb Haemost. 2017 May 3;117(5):880-888
pubmed: 28229161
IUBMB Life. 2009 Jan;61(1):1-5
pubmed: 18785256
Br J Haematol. 2017 Jul;178(2):279-285
pubmed: 28317092
Mol Med. 2012 Jul 18;18:762-70
pubmed: 22481271
Thromb Haemost. 2011 Apr;105(4):635-46
pubmed: 21264449
Prion. 2009 Jan-Mar;3(1):12-4
pubmed: 19372754
J Biosci Bioeng. 2005 Mar;99(3):264-71
pubmed: 16233787
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4467-72
pubmed: 22392975
Blood. 2003 Dec 1;102(12):4028-34
pubmed: 12907439
Clin Sci (Lond). 1994 May;86(5):489-95
pubmed: 8033502
J Thromb Haemost. 2004 Jun;2(6):931-9
pubmed: 15140129
Biopolymers. 2008 May;89(5):392-400
pubmed: 17896349
Eur Respir J. 2016 Mar;47(3):1005-9
pubmed: 26846838
J Biol Chem. 2017 Oct 6;292(40):16513-16520
pubmed: 28743742
FASEB J. 2015 Jun;29(6):2667-78
pubmed: 25757566
Protein Eng. 1990 Apr;3(5):433-42
pubmed: 2349213
J Mol Biol. 2003 Feb 21;326(3):823-33
pubmed: 12581643
Genome Res. 2000 Dec;10(12):1845-64
pubmed: 11116082
Thromb Haemost. 2016 Jul 4;116(1):146-54
pubmed: 27098529
Biochem J. 1983 Feb 1;209(2):331-6
pubmed: 6847620
Proteins. 1995 Dec;23(4):566-79
pubmed: 8749853
J Biol Chem. 2010 Oct 1;285(40):30752-8
pubmed: 20667823
Proc Natl Acad Sci U S A. 1977 Jan;74(1):134-8
pubmed: 264667
Anal Biochem. 2000 Dec 15;287(2):252-60
pubmed: 11112271
J Clin Invest. 2002 Dec;110(11):1585-90
pubmed: 12464660
Biochim Biophys Acta. 2015 Feb;1854(2):110-7
pubmed: 25450507
J Biol Chem. 2006 May 12;281(19):13424-32
pubmed: 16517611

Auteurs

Sonia Águila (S)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.

Rosina Noto (R)

Institute of Biophysics (IBF), National Research Council of Italy (CNR), 153-90146 Palermo, Italy.

Ginés Luengo-Gil (G)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.

Salvador Espín (S)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.

Nataliya Bohdan (N)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.

María Eugenia de la Morena-Barrio (ME)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.
Grupo de investigación CB15/00055 del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII) Madrid, 28029 Madrid, Spain.

Julia Peñas (J)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.

Maria Carmen Rodenas (MC)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.

Vicente Vicente (V)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.
Grupo de investigación CB15/00055 del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII) Madrid, 28029 Madrid, Spain.

Javier Corral (J)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.
Grupo de investigación CB15/00055 del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII) Madrid, 28029 Madrid, Spain.

Mauro Manno (M)

Institute of Biophysics (IBF), National Research Council of Italy (CNR), 153-90146 Palermo, Italy.

Irene Martínez-Martínez (I)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia Campus Mare Nostrum, IMIB-Arrixaca, 30008 Murcia, Spain.
Grupo de investigación CB15/00055 del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII) Madrid, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH